The Fortnight's Reading
News
Dispatches on the regulatory, infrastructure and clinical developments moving through Asian regenerative medicine — filed once the dust has settled enough to see what actually changed.
News, Read Twice
MFDS Clarifies Position on SVF Procedures
Korea's regulator returns to the autologous stromal vascular fraction question — and the clarification reads, on close inspection, rather more carefully than the headline summaries suggest.
Read article →News, Read Twice
Korea Visa Updates for Medical Travelers: 2026 Editor Reading
A measured editorial summary of Korea's 2026 entry framework — K-ETA, the C-3-3 medical lane, and what changed quietly between 2024 and now.
Read article →News, Read Twice
Korean Cell Therapy Research Grants and What They Signal
Reading 2026 funding flows — quietly, the way one reads a wine list at the Mandarin
Read article →News, Read Twice
KHIDI's 2026 Foreign Patient Registration Update
A timeline reading of the 2026 amendments — registration, indemnity, disclosure, and the quiet shift in what the agency now expects.
Read article →